U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 395

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:65508902-67473140
GRCh38:
Chr11:65741431-67705669
LOC130006205, LOC130006206, LOC130006207, LOC130006208, LOC130006209, LOC130006210, LOC130006211, LOC130006212, LOC130006213, LOC130006214, LOC130006215, LOC130006216, LOC130006217, LOC130006218, LOC130006219, LOC130006220, LOC130006221, LOC130006222, LOC130006223, LOC130006224, LOC130006225, LOC130006226, LOC130006227, LOC130006228, LOC130006229, LRFN4, MIR3163, MIR6752, MIR6860, MRPL11, MUS81, NDUFV1, NDUFV1-DT, NPAS4, NUDT8, OVOL1, OVOL1-AS1, PACS1, PC, PELI3, PITPNM1, POLD4, PPP1CA, PTPRCAP, RAB1B, RAD9A, RBM14, RBM14-RBM4, RBM4, RBM4B, RCE1, RHOD, RIN1, RPS6KB2, SART1, SF3B2, SLC29A2, SNORD13F, SNX32, SPTBN2, SSH3, SYT12, TBC1D10C, TBX10, TMEM134, TMEM151A, TOP6BL, TRS-GCT3-1, TSGA10IP, YIF1A, ZDHHC24, ACTN3, ACY3, AIP, ALDH3B2, ANKRD13D, AP5B1, B4GAT1, B4GAT1-DT, BANF1, BBS1, BRMS1, C11orf68, C11orf86, CABP2, CABP4, CARNS1, CATSPER1, CCDC85B, CCDC87, CCS, CD248, CDK2AP2, CFL1, CLCF1, CNIH2, CORO1B, CST6, CTSF, CTSW, DPP3, DPP3-DT, DRAP1, EFEMP2, EIF1AD, FIBP, FOSL1, FRA11A, GAL3ST3, GPR152, GRK2, GSTP1, KDM2A, KLC2, KLC2-AS1, KLC2-AS2, LOC100130987, LOC107984341, LOC111413017, LOC111718491, LOC112081411, LOC112081412, LOC113939926, LOC116216147, LOC116216148, LOC121832794, LOC124500672, LOC124500673, LOC124500674, LOC124500675, LOC124500676, LOC124500677, LOC124500678, LOC126861238, LOC126861239, LOC126861240, LOC126861241, LOC126861242, LOC129390293, LOC129390294, LOC129390295, LOC129390296, LOC130006063, LOC130006064, LOC130006065, LOC130006066, LOC130006067, LOC130006068, LOC130006069, LOC130006070, LOC130006071, LOC130006072, LOC130006073, LOC130006074, LOC130006075, LOC130006076, LOC130006077, LOC130006078, LOC130006079, LOC130006080, LOC130006081, LOC130006082, LOC130006083, LOC130006084, LOC130006085, LOC130006086, LOC130006087, LOC130006088, LOC130006089, LOC130006090, LOC130006091, LOC130006092, LOC130006093, LOC130006094, LOC130006095, LOC130006096, LOC130006097, LOC130006098, LOC130006099, LOC130006100, LOC130006101, LOC130006102, LOC130006103, LOC130006104, LOC130006105, LOC130006106, LOC130006107, LOC130006108, LOC130006109, LOC130006110, LOC130006111, LOC130006112, LOC130006113, LOC130006114, LOC130006115, LOC130006116, LOC130006117, LOC130006118, LOC130006119, LOC130006120, LOC130006121, LOC130006122, LOC130006123, LOC130006124, LOC130006125, LOC130006126, LOC130006127, LOC130006128, LOC130006129, LOC130006130, LOC130006131, LOC130006132, LOC130006133, LOC130006134, LOC130006135, LOC130006136, LOC130006137, LOC130006138, LOC130006139, LOC130006140, LOC130006141, LOC130006142, LOC130006143, LOC130006144, LOC130006145, LOC130006146, LOC130006147, LOC130006148, LOC130006149, LOC130006150, LOC130006151, LOC130006152, LOC130006153, LOC130006154, LOC130006155, LOC130006156, LOC130006157, LOC130006158, LOC130006159, LOC130006160, LOC130006161, LOC130006162, LOC130006163, LOC130006164, LOC130006165, LOC130006166, LOC130006167, LOC130006168, LOC130006169, LOC130006170, LOC130006171, LOC130006172, LOC130006173, LOC130006174, LOC130006175, LOC130006176, LOC130006177, LOC130006178, LOC130006179, LOC130006180, LOC130006181, LOC130006182, LOC130006183, LOC130006184, LOC130006185, LOC130006186, LOC130006187, LOC130006188, LOC130006189, LOC130006190, LOC130006191, LOC130006192, LOC130006193, LOC130006194, LOC130006195, LOC130006196, LOC130006197, LOC130006198, LOC130006199, LOC130006200, LOC130006201, LOC130006202, LOC130006203, LOC130006204
See casesPathogenic
(Oct 24, 2012)
no assertion criteria provided
2.
GRCh37:
Chr11:65960973-67658241
GRCh38:
Chr11:66193502-67890770
RIN1, RPS6KB2, SLC29A2, SPTBN2, SSH3, SYT12, TBC1D10C, TBX10, TMEM134, TMEM151A, TOP6BL, TRS-GCT3-1, YIF1A, ZDHHC24, ACTN3, ACY3, AIP, ALDH3B2, ANKRD13D, B4GAT1, B4GAT1-DT, BBS1, BRMS1, C11orf86, CABP2, CABP4, CARNS1, CCDC87, CCS, CD248, CDK2AP2, CLCF1, CNIH2, CORO1B, CTSF, DPP3, DPP3-DT, FRA11A, GPR152, GRK2, GSTP1, KDM2A, KLC2, KLC2-AS1, KLC2-AS2, LINC02754, LOC100130987, LOC107984341, LOC111718491, LOC112081411, LOC112081412, LOC113939926, LOC124500675, LOC124500676, LOC124500677, LOC124500678, LOC126861238, LOC126861239, LOC126861240, LOC126861241, LOC126861242, LOC129390293, LOC129390294, LOC129390295, LOC129390296, LOC130006106, LOC130006107, LOC130006108, LOC130006109, LOC130006110, LOC130006111, LOC130006112, LOC130006113, LOC130006114, LOC130006115, LOC130006116, LOC130006117, LOC130006118, LOC130006119, LOC130006120, LOC130006121, LOC130006122, LOC130006123, LOC130006124, LOC130006125, LOC130006126, LOC130006127, LOC130006128, LOC130006129, LOC130006130, LOC130006131, LOC130006132, LOC130006133, LOC130006134, LOC130006135, LOC130006136, LOC130006137, LOC130006138, LOC130006139, LOC130006140, LOC130006141, LOC130006142, LOC130006143, LOC130006144, LOC130006145, LOC130006146, LOC130006147, LOC130006148, LOC130006149, LOC130006150, LOC130006151, LOC130006152, LOC130006153, LOC130006154, LOC130006155, LOC130006156, LOC130006157, LOC130006158, LOC130006159, LOC130006160, LOC130006161, LOC130006162, LOC130006163, LOC130006164, LOC130006165, LOC130006166, LOC130006167, LOC130006168, LOC130006169, LOC130006170, LOC130006171, LOC130006172, LOC130006173, LOC130006174, LOC130006175, LOC130006176, LOC130006177, LOC130006178, LOC130006179, LOC130006180, LOC130006181, LOC130006182, LOC130006183, LOC130006184, LOC130006185, LOC130006186, LOC130006187, LOC130006188, LOC130006189, LOC130006190, LOC130006191, LOC130006192, LOC130006193, LOC130006194, LOC130006195, LOC130006196, LOC130006197, LOC130006198, LOC130006199, LOC130006200, LOC130006201, LOC130006202, LOC130006203, LOC130006204, LOC130006205, LOC130006206, LOC130006207, LOC130006208, LOC130006209, LOC130006210, LOC130006211, LOC130006212, LOC130006213, LOC130006214, LOC130006215, LOC130006216, LOC130006217, LOC130006218, LOC130006219, LOC130006220, LOC130006221, LOC130006222, LOC130006223, LOC130006224, LOC130006225, LOC130006226, LOC130006227, LOC130006228, LOC130006229, LOC130006230, LRFN4, MIR3163, MIR6752, MIR6860, MRPL11, NDUFV1, NDUFV1-DT, NPAS4, NUDT8, PACS1, PC, PELI3, PITPNM1, POLD4, PPP1CA, PTPRCAP, RAB1B, RAD9A, RBM14, RBM14-RBM4, RBM4, RBM4B, RCE1, RHOD
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
3.
GRCh37:
Chr11:66653381-67465721
GRCh38:
Chr11:66885910-67698250
ACY3, AIP, ALDH3B2, ANKRD13D, C11orf86, CABP2, CABP4, CARNS1, CDK2AP2, CLCF1, CORO1B, GPR152, GRK2, GSTP1, KDM2A, LOC100130987, LOC107984341, LOC124500677, LOC124500678, LOC126861239, LOC126861240, LOC126861241, LOC126861242, LOC129390295, LOC129390296, LOC130006143, LOC130006144, LOC130006145, LOC130006146, LOC130006147, LOC130006148, LOC130006149, LOC130006150, LOC130006151, LOC130006152, LOC130006153, LOC130006154, LOC130006155, LOC130006156, LOC130006157, LOC130006158, LOC130006159, LOC130006160, LOC130006161, LOC130006162, LOC130006163, LOC130006164, LOC130006165, LOC130006166, LOC130006167, LOC130006168, LOC130006169, LOC130006170, LOC130006171, LOC130006172, LOC130006173, LOC130006174, LOC130006175, LOC130006176, LOC130006177, LOC130006178, LOC130006179, LOC130006180, LOC130006181, LOC130006182, LOC130006183, LOC130006184, LOC130006185, LOC130006186, LOC130006187, LOC130006188, LOC130006189, LOC130006190, LOC130006191, LOC130006192, LOC130006193, LOC130006194, LOC130006195, LOC130006196, LOC130006197, LOC130006198, LOC130006199, LOC130006200, LOC130006201, LOC130006202, LOC130006203, LOC130006204, LOC130006205, LOC130006206, LOC130006207, LOC130006208, LOC130006209, LOC130006210, LOC130006211, LOC130006212, LOC130006213, LOC130006214, LOC130006215, LOC130006216, LOC130006217, LOC130006218, LOC130006219, LOC130006220, LOC130006221, LOC130006222, LOC130006223, LOC130006224, LOC130006225, LOC130006226, LOC130006227, LOC130006228, LOC130006229, MIR3163, MIR6752, MIR6860, NDUFV1, NDUFV1-DT, NUDT8, PC, PITPNM1, POLD4, PPP1CA, PTPRCAP, RAD9A, RHOD, RPS6KB2, SSH3, SYT12, TBC1D10C, TBX10, TMEM134
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
4.
GRCh37:
Chr11:66984735-69263366
GRCh38:
Chr11:67217264-69448598
ACY3, AIP, ALDH3B1, ALDH3B2, ANKRD13D, C11orf24, CABP2, CABP4, CARNS1, CDK2AP2, CHKA, CHKA-DT, CLCF1, CORO1B, CPT1A, GAL, GPR152, GRK2, GSTP1, IGHMBP2, KDM2A, KMT5B, LINC02754, LINC02952, LINC02953, LOC100130987, LOC105369367, LOC110121479, LOC111413018, LOC112081413, LOC112081415, LOC112081416, LOC112136078, LOC116216149, LOC116216150, LOC121392924, LOC121832795, LOC121832796, LOC124500678, LOC124500679, LOC124500680, LOC126861240, LOC126861241, LOC126861242, LOC126861243, LOC126861244, LOC126861245, LOC126861246, LOC126861247, LOC126861248, LOC129390296, LOC129390297, LOC129390298, LOC130006167, LOC130006168, LOC130006169, LOC130006170, LOC130006171, LOC130006172, LOC130006173, LOC130006174, LOC130006175, LOC130006176, LOC130006177, LOC130006178, LOC130006179, LOC130006180, LOC130006181, LOC130006182, LOC130006183, LOC130006184, LOC130006185, LOC130006186, LOC130006187, LOC130006188, LOC130006189, LOC130006190, LOC130006191, LOC130006192, LOC130006193, LOC130006194, LOC130006195, LOC130006196, LOC130006197, LOC130006198, LOC130006199, LOC130006200, LOC130006201, LOC130006202, LOC130006203, LOC130006204, LOC130006205, LOC130006206, LOC130006207, LOC130006208, LOC130006209, LOC130006210, LOC130006211, LOC130006212, LOC130006213, LOC130006214, LOC130006215, LOC130006216, LOC130006217, LOC130006218, LOC130006219, LOC130006220, LOC130006221, LOC130006222, LOC130006223, LOC130006224, LOC130006225, LOC130006226, LOC130006227, LOC130006228, LOC130006229, LOC130006230, LOC130006231, LOC130006232, LOC130006233, LOC130006234, LOC130006235, LOC130006236, LOC130006237, LOC130006238, LOC130006239, LOC130006240, LOC130006241, LOC130006242, LOC130006243, LOC130006244, LOC130006245, LOC130006246, LOC130006247, LOC130006248, LOC130006249, LOC130006250, LOC130006251, LOC130006252, LOC130006253, LOC130006254, LOC130006255, LOC130006256, LOC130006257, LOC130006258, LOC130006259, LOC130006260, LOC130006261, LOC130006262, LOC130006263, LOC130006264, LOC130006265, LOC130006266, LOC130006267, LOC130006268, LOC130006269, LOC130006270, LOC130006271, LOC130006272, LOC130006273, LOC130006274, LOC130006275, LOC130006276, LOC130006277, LOC130006278, LOC130006279, LOC130006280, LOC130006281, LOC130006282, LOC130006283, LOC130006284, LOC130006285, LOC130006286, LOC130006287, LOC130006288, LOC130006289, LOC338694, LRP5, MIR3164, MIR4691, MIR6752, MIR6753, MIR7113, MRGPRD, MRGPRF, MRGPRF-AS1, MRPL21, MYEOV, NDUFS8, NDUFV1, NDUFV1-DT, NUDT8, PITPNM1, POLD4, PPP1CA, PPP6R3, PTPRCAP, RAD9A, RPS6KB2, SMIM38, SSH3, TBC1D10C, TBX10, TCIRG1, TESMIN, TMEM134, TPCN2, UNC93B1
See casesLikely pathogenic
(Aug 5, 2011)
no assertion criteria provided
5.
GRCh37:
Chr11:67164667-67411909
GRCh38:
Chr11:67397196-67644438
See casesBenign
(Jan 30, 2010)
no assertion criteria provided
6.
GRCh37:
Chr11:67213624-68446541
GRCh38:
Chr11:67446153-68679073
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
7.
GRCh37:
Chr11:67219930
GRCh38:
Chr11:67452459
CABP4, GPR152L89PInborn genetic diseasesUncertain significance
(May 4, 2023)
criteria provided, single submitter
8.
GRCh37:
Chr11:67220003
GRCh38:
Chr11:67452532
CABP4, GPR152R65CInborn genetic diseasesUncertain significance
(Sep 16, 2021)
criteria provided, single submitter
9.
GRCh37:
Chr11:67220015
GRCh38:
Chr11:67452544
CABP4, GPR152G61RCone-rod synaptic disorder, congenital nonprogressiveBenign
(May 28, 2019)
criteria provided, single submitter
10.
GRCh37:
Chr11:67220016
GRCh38:
Chr11:67452545
CABP4, GPR152H60QInborn genetic diseasesLikely benign
(Apr 11, 2023)
criteria provided, single submitter
11.
GRCh37:
Chr11:67220035
GRCh38:
Chr11:67452564
CABP4, GPR152A54VInborn genetic diseasesUncertain significance
(Feb 6, 2023)
criteria provided, single submitter
12.
GRCh37:
Chr11:67220139
GRCh38:
Chr11:67452668
CABP4, GPR152E19DInborn genetic diseasesUncertain significance
(Aug 4, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr11:67222605
GRCh38:
Chr11:67455134
CABP4not providedBenign
(Jul 6, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr11:67222868
GRCh38:
Chr11:67455397
CABP4Cone-rod synaptic disorder, congenital nonprogressiveUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr11:67222898
GRCh38:
Chr11:67455427
CABP4T2Anot providedUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr11:67222904
GRCh38:
Chr11:67455433
CABP4E4Qnot provided, Cone-rod synaptic disorder, congenital nonprogressive, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
17.
GRCh37:
Chr11:67222909
GRCh38:
Chr11:67455438
CABP4Q5Hnot providedUncertain significance
(Feb 19, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr11:67222915
GRCh38:
Chr11:67455444
CABP4R7Snot providedUncertain significance
(Jun 4, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr11:67222918
GRCh38:
Chr11:67455447
CABP4not providedLikely benign
(Jun 9, 2021)
criteria provided, single submitter
20.
GRCh37:
Chr11:67222930
GRCh38:
Chr11:67455459
CABP4not providedLikely benign
(Sep 16, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr11:67222936
GRCh38:
Chr11:67455465
CABP4not providedLikely benign
(Oct 9, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr11:67222940
GRCh38:
Chr11:67455469
CABP4I16Vnot providedUncertain significance
(Sep 2, 2021)
criteria provided, single submitter
23.
GRCh37:
Chr11:67222941
GRCh38:
Chr11:67455470
CABP4I16TInborn genetic diseases, not providedConflicting interpretations of pathogenicity
(Oct 12, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr11:67222944
GRCh38:
Chr11:67455473
CABP4G17Anot providedBenign
(Nov 1, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr11:67222946
GRCh38:
Chr11:67455475
CABP4R18Cnot providedUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr11:67222947
GRCh38:
Chr11:67455476
CABP4R18Hnot provided, Cone-rod synaptic disorder, congenital nonprogressiveBenign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr11:67222953
GRCh38:
Chr11:67455482
CABP4K20Rnot providedUncertain significance
(May 24, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr11:67222955
GRCh38:
Chr11:67455484
CABP4P22fsRetinal dystrophy, Cone-rod synaptic disorder, congenital nonprogressivePathogenic/Likely pathogenic
(Jun 1, 2021)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr11:67222955-67222956
GRCh38:
Chr11:67455484-67455485
CABP4P21fsCone-rod synaptic disorder, congenital nonprogressivePathogenic
(Jan 25, 2019)
no assertion criteria provided
30.
GRCh37:
Chr11:67222958
GRCh38:
Chr11:67455487
CABP4P22Anot providedUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
31.
GRCh37:
Chr11:67222959
GRCh38:
Chr11:67455488
CABP4P22Lnot providedUncertain significance
(Sep 12, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr11:67222959-67222960
GRCh38:
Chr11:67455488-67455489
CABP4A23fsnot providedPathogenic
(Jun 21, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr11:67222962
GRCh38:
Chr11:67455491
CABP4A23Vnot providedLikely benign
(Jul 19, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr11:67222962
GRCh38:
Chr11:67455491
CABP4A23Gnot providedUncertain significance
(Sep 2, 2021)
criteria provided, single submitter
35.
GRCh37:
Chr11:67222963
GRCh38:
Chr11:67455492
CABP4not provided, Cone-rod synaptic disorder, congenital nonprogressiveConflicting interpretations of pathogenicity
(Sep 20, 2022)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr11:67222966
GRCh38:
Chr11:67455495
CABP4not providedUncertain significance
(Oct 29, 2015)
criteria provided, single submitter
37.
GRCh37:
Chr11:67222967
GRCh38:
Chr11:67455496
CABP4V25Fnot providedUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr11:67222967
GRCh38:
Chr11:67455496
CABP4V25Inot providedUncertain significance
(Jun 23, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr11:67222968
GRCh38:
Chr11:67455497
CABP4V25Anot providedUncertain significance
(Aug 18, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr11:67222975-67222976
GRCh38:
Chr11:67455504-67455505
CABP4P28fsnot providedPathogenic
(Apr 14, 2020)
criteria provided, single submitter
41.
GRCh37:
Chr11:67222980
GRCh38:
Chr11:67455509
CABP4K29Rnot providedUncertain significance
(Jan 17, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr11:67222981
GRCh38:
Chr11:67455510
CABP4not providedLikely benign
(Oct 13, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr11:67222996
GRCh38:
Chr11:67455525
CABP4not providedUncertain significance
(Mar 10, 2015)
criteria provided, single submitter
44.
GRCh37:
Chr11:67223001
GRCh38:
Chr11:67455530
CABP4P36Rnot providedUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr11:67223002
GRCh38:
Chr11:67455531
CABP4not providedLikely benign
(Jun 18, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr11:67223003
GRCh38:
Chr11:67455532
CABP4not providedLikely benign
(May 27, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr11:67223007
GRCh38:
Chr11:67455536
CABP4T38Inot providedUncertain significance
(Sep 17, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr11:67223023
GRCh38:
Chr11:67455552
CABP4not providedLikely benign
(Apr 12, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr11:67223031
GRCh38:
Chr11:67455560
CABP4R46Tnot providedUncertain significance
(Aug 30, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr11:67223033
GRCh38:
Chr11:67455562
CABP4G47Rnot providedUncertain significance
(May 10, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr11:67223037
GRCh38:
Chr11:67455566
CABP4L48Hnot providedUncertain significance
(Feb 24, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr11:67223039
GRCh38:
Chr11:67455568
CABP4R49*not providedPathogenic
(Aug 26, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr11:67223040
GRCh38:
Chr11:67455569
CABP4R49Qnot providedUncertain significance
(Nov 1, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr11:67223048
GRCh38:
Chr11:67455577
CABP4R52Gnot providedUncertain significance
(Jul 23, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr11:67223048
GRCh38:
Chr11:67455577
CABP4R52*not providedPathogenic
(Jul 26, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr11:67223049
GRCh38:
Chr11:67455578
CABP4R52Qnot providedConflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr11:67223071
GRCh38:
Chr11:67455600
CABP4not providedUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr11:67223081
GRCh38:
Chr11:67455610
CABP4G63Snot providedConflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
59.
GRCh37:
Chr11:67223086
GRCh38:
Chr11:67455615
CABP4not providedLikely benign
(Nov 1, 2021)
criteria provided, single submitter
60.
GRCh37:
Chr11:67223086
GRCh38:
Chr11:67455615
CABP4not specified, not provided, Cone-rod synaptic disorder, congenital nonprogressive
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr11:67223087
GRCh38:
Chr11:67455616
CABP4E65Knot providedLikely benign
(Aug 22, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr11:67223088
GRCh38:
Chr11:67455617
CABP4E65GCone-rod synaptic disorder, congenital nonprogressiveUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr11:67223094
GRCh38:
Chr11:67455623
CABP4P67Lnot providedUncertain significance
(Feb 9, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr11:67223095
GRCh38:
Chr11:67455624
CABP4not providedLikely benign
(Mar 2, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr11:67223101
GRCh38:
Chr11:67455630
CABP4not providedLikely benign
(Mar 20, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr11:67223108
GRCh38:
Chr11:67455637
CABP4N72Hnot provided, Cone-rod synaptic disorder, congenital nonprogressiveConflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
67.
GRCh37:
Chr11:67223110
GRCh38:
Chr11:67455639
CABP4not providedLikely benign
(Nov 23, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr11:67223114
GRCh38:
Chr11:67455643
CABP4P74TInborn genetic diseasesUncertain significance
(Jun 30, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr11:67223122
GRCh38:
Chr11:67455651
CABP4not provided, Cone-rod synaptic disorder, congenital nonprogressiveConflicting interpretations of pathogenicity
(Jul 5, 2022)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr11:67223124-67223125
GRCh38:
Chr11:67455653-67455654
CABP4E78fsnot providedPathogenic
(Apr 26, 2017)
criteria provided, single submitter
71.
GRCh37:
Chr11:67223124
GRCh38:
Chr11:67455653
CABP4G77Anot provided, Inborn genetic diseases, Cone-rod synaptic disorder, congenital nonprogressive
Uncertain significance
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr11:67223127
GRCh38:
Chr11:67455656
CABP4E78Vnot providedUncertain significance
(Aug 26, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr11:67223133
GRCh38:
Chr11:67455662
CABP4P80Lnot providedUncertain significance
(Feb 10, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr11:67223136
GRCh38:
Chr11:67455665
CABP4A81VCongenital Stationary Night Blindness, Recessive, not providedConflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
75.
GRCh37:
Chr11:67223137
GRCh38:
Chr11:67455666
CABP4not providedLikely benign
(Jul 9, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr11:67223140
GRCh38:
Chr11:67455669
CABP4not providedLikely benign
(Sep 15, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr11:67223140
GRCh38:
Chr11:67455669
CABP4Cone-rod synaptic disorder, congenital nonprogressive, not providedConflicting interpretations of pathogenicity
(Oct 21, 2022)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr11:67223141
GRCh38:
Chr11:67455670
CABP4A83Pnot providedUncertain significance
(Aug 11, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr11:67223141
GRCh38:
Chr11:67455670
CABP4A83Tnot providedUncertain significance
(Sep 10, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr11:67223144
GRCh38:
Chr11:67455673
CABP4P84Tnot providedUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr11:67223147
GRCh38:
Chr11:67455676
CABP4P85Snot providedUncertain significance
(Mar 31, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr11:67223150
GRCh38:
Chr11:67455679
CABP4A86Tnot providedUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr11:67223153
GRCh38:
Chr11:67455682
CABP4S87Tnot providedUncertain significance
(Sep 6, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr11:67223154
GRCh38:
Chr11:67455683
CABP4S87CInborn genetic diseases, not providedUncertain significance
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr11:67223154
GRCh38:
Chr11:67455683
CABP4S87Fnot providedUncertain significance
(Sep 24, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr11:67223156
GRCh38:
Chr11:67455685
CABP4P88Snot providedUncertain significance
(Nov 1, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr11:67223158
GRCh38:
Chr11:67455687
CABP4not providedLikely benign
(Nov 9, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr11:67223163
GRCh38:
Chr11:67455692
CABP4P90Lnot providedUncertain significance
(Mar 10, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr11:67223164
GRCh38:
Chr11:67455693
CABP4not providedLikely benign
(Oct 5, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr11:67223170
GRCh38:
Chr11:67455699
CABP4not providedLikely benign
(Aug 8, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr11:67223174
GRCh38:
Chr11:67455703
CABP4R94Cnot providedUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr11:67223175
GRCh38:
Chr11:67455704
CABP4R94Pnot providedUncertain significance
(Jul 11, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr11:67223175
GRCh38:
Chr11:67455704
CABP4R94HCone-rod synaptic disorder, congenital nonprogressive, not providedConflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr11:67223178
GRCh38:
Chr11:67455707
CABP4Q95RInborn genetic diseasesUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr11:67223186
GRCh38:
Chr11:67455715
CABP4R98*not providedPathogenic
(Mar 17, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr11:67223187
GRCh38:
Chr11:67455716
CABP4R98Qnot providedUncertain significance
(Oct 13, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr11:67223190
GRCh38:
Chr11:67455719
CABP4H99Lnot providedUncertain significance
(Jun 27, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr11:67223193
GRCh38:
Chr11:67455722
CABP4R100Hnot providedBenign
(Nov 1, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr11:67223203
GRCh38:
Chr11:67455732
CABP4Cone-rod synaptic disorder, congenital nonprogressive, not providedConflicting interpretations of pathogenicity
(Mar 20, 2022)
criteria provided, conflicting interpretations
100.
GRCh37:
Chr11:67223209
GRCh38:
Chr11:67455738
CABP4Cone-rod synaptic disorder, congenital nonprogressive, not providedConflicting interpretations of pathogenicity
(Feb 23, 2020)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination